200 related articles for article (PubMed ID: 7860480)
1. Chemotherapy induced refractory anaemia with ring sideroblasts in carcinoma breast.
Dhot PS; Sharma MC; Kumar L; Saxena R
J Assoc Physicians India; 1994 Feb; 42(2):153-4. PubMed ID: 7860480
[No Abstract] [Full Text] [Related]
2. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
Gül U; Kiliç A
Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
[No Abstract] [Full Text] [Related]
3. Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer.
Mortimer J; Livingston RB; Hardesty IJ; Groppe CW; Purvis JD; Gupta M; Flournoy N
Cancer Treat Rep; 1984; 68(7-8):1017-8. PubMed ID: 6744334
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study].
Pribylová O; Petruzelka L; Honová H; Fischer J; Bustová I; Siffnerová H; Kůta M; Miller V; Hacklová M; Machácek J; Kohoutek M; Vodvárka P; Kyselá T; Tajblová J; Suk J; Dorazilová V; Bauer J
Sb Lek; 1998; 99(1):25-31. PubMed ID: 9748796
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
6. [Leukemia in patients with breast carcinoma after adjuvant chemotherapy and/or postoperative radiotherapy].
Sack H
Strahlenther Onkol; 1995 Jul; 171(7):420-1. PubMed ID: 7631268
[No Abstract] [Full Text] [Related]
7. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
8. [Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma].
Hofmann M; Mahlke M; Casper F; Brockerhoff P
Zentralbl Gynakol; 1995; 117(6):314-6. PubMed ID: 7544054
[TBL] [Abstract][Full Text] [Related]
9. [Platelet aggregation during adjuvant chemotherapy with CMF].
Sbalzarini G; Pandolfi C; Labadini A
Minerva Med; 1991 Jun; 82(6):367-70. PubMed ID: 1648685
[TBL] [Abstract][Full Text] [Related]
10. [Radiotherapy of carcinoma of the breast].
Sinistrero G; Zola P; Sussio M; Giurgola L; Lio V
Minerva Ginecol; 1985 Jun; 37(6):275-80. PubMed ID: 3839915
[No Abstract] [Full Text] [Related]
11. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient.
Porta C; Casagranda I; Semino G; Moroni M; Ratto C
Haematologica; 1993; 78(1):56-7. PubMed ID: 8387943
[No Abstract] [Full Text] [Related]
12. Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
Gianni L; Baselga J; Eiermann W; Guillem Porta V; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Llombart Cussac A; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez Lopez JJ; Mansutti M; Valagussa P; Bonadonna G;
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8715-21. PubMed ID: 16361558
[TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
[TBL] [Abstract][Full Text] [Related]
15. [Value of chemotherapy preceding exclusive conservative loco-regional radiotherapy in breast cancer].
Baillet F; Housset M; Khayat D; Rozec C; Ucla L; Maulard C; Brunel P; Hu BQ; Delanian S
Pathol Biol (Paris); 1992 Nov; 39(9):933-4. PubMed ID: 1538940
[No Abstract] [Full Text] [Related]
16. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.
Bellon JR; Come SE; Gelman RS; Henderson IC; Shulman LN; Silver BJ; Harris JR; Recht A
J Clin Oncol; 2005 Mar; 23(9):1934-40. PubMed ID: 15774786
[TBL] [Abstract][Full Text] [Related]
17. [Secondary effects of adjuvant therapy].
Giai M; De Fabiani E; Lamberto A; Cortese P; Giardina G
Minerva Ginecol; 1985 Jun; 37(6):319-28. PubMed ID: 3162112
[No Abstract] [Full Text] [Related]
18. In regards to Arcangeli et al. (Int J Radiat Oncol Biol Phys 2006;64:161-167).
Munshi A; Jalali R; Budrukar A
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):632; author reply 632-3. PubMed ID: 16690446
[No Abstract] [Full Text] [Related]
19. Adjuvant chemotherapy in breast cancer: back to the future.
Colleoni M; Goldhirsch A
Onkologie; 2003 Apr; 26(2):111-2. PubMed ID: 12771517
[No Abstract] [Full Text] [Related]
20. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]